Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.45 |
| ▸ | ITGAV | P06756 | 1/20 | 0.45 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.45 |
| ▸ | NMT1 | P30419 | 1/20 | 0.45 |
| ▸ | ABAT | P80404 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11787774 | 0.84 | ABAT (0.62) | POLBSMN1; SMN2ITGB3ITGB1ITGAV | |
| SCHEMBL20335100 | 0.82 | ALDH1A1 (0.71) | ALDH1A1POLBTDP1NPC1RAB9A | |
| SCHEMBL25840794 | 0.79 | ABAT (0.72) | ALDH1A1POLBNPC1RAB9AMAPT | |
| SCHEMBL10522147 | 0.79 | SAE1 (0.50) | ALDH1A1POLBRAB9AMAPTABAT | |
| SCHEMBL23328671 | 0.79 | EPHX2 (0.54) | ALDH1A1POLBNPC1RAB9AMEN1 | |
| SCHEMBL20335060 | 0.77 | ALDH1A1 (0.63) | ALDH1A1POLBNPC1RAB9AMAPT | |
| SCHEMBL20335038 | 0.77 | ALDH1A1 (0.63) | ALDH1A1POLBNPC1RAB9AMAPT | |
| SCHEMBL678436 | 0.77 | TDP1 (0.56) | POLBTDP1NPC1RAB9AMAPT | |
| P-Xylene SCHEMBL28329564 | 0.77 | EGLN1 (0.50) | ALDH1A1POLBTDP1NPC1RAB9A | |
| SCHEMBL25840791 | 0.75 | CA12 (0.46) | ALDH1A1POLBTDP1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11701333-B2 | Antibacterial compounds | Kent Innovation & Enterprise (GB) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11701333-B2 | Antibacterial compounds | ARF1, ARL1, TLR1 | ALDH1A1 465/4885POLB 3462/4885TDP1 4431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.